Douglas Carr sold $404 of Century Therapeutics stock
By AlphaYouPublished Form 4
Carr Douglas
Reporting filer
Douglas Carr reported selling 266 shares of Century Therapeutics, Inc. for about $404 ($1.52 a share on average). Form 4 filed Nov 5, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Carr Douglas | 2026-11-03 | S | Sale | 266 | 1.519 | 502,641 | 2 days | Filed terms
|
Common Stock
- Owner
- Carr Douglas
- Date
- 2026-11-03
- Code
- S
- Action
- Sale
- Quantity
- 266
- Price
- 1.519
- Following holdings
- 502,641
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-03
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 266
- transaction Price Per Share: 1.519
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 502641
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Carr Douglas: SVP Finance & Operations.
- F1: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Original sources
Prepared automatically from public filing data. Report a correction.